AMG 133
AMG 133 is a pharmaceutical drug currently under investigation for its potential therapeutic effects in the treatment of various mental health disorders. It is a novel, selective antagonist of the glutamate receptor subtype 5 (mGluR5), which plays a crucial role in the neurotransmission process.
Mechanism of Action[edit | edit source]
AMG 133 works by selectively blocking the mGluR5 receptors in the brain. These receptors are involved in the regulation of glutamate, an important neurotransmitter in the central nervous system. By inhibiting these receptors, AMG 133 can potentially modulate the glutamatergic system and alleviate symptoms associated with various mental health disorders.
Clinical Trials[edit | edit source]
Several clinical trials have been conducted to evaluate the safety, tolerability, and efficacy of AMG 133. These trials have shown promising results, suggesting that AMG 133 could be a potential treatment option for disorders such as schizophrenia, anxiety disorders, and major depressive disorder.
Potential Side Effects[edit | edit source]
As with any pharmaceutical drug, AMG 133 may cause side effects. These can include nausea, headache, and dizziness. However, these side effects are generally mild and manageable.
Future Research[edit | edit source]
Further research is needed to fully understand the therapeutic potential of AMG 133. This includes additional clinical trials to evaluate its long-term safety and efficacy, as well as studies to explore its mechanism of action in more detail.
 | This medical article is a stub. You can help WikiMD by expanding it. |
Translate: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
References[edit | edit source]
External Links[edit | edit source]
- ClinicalTrials.gov: A Study of AMG 133 in Healthy Subjects and Subjects With Schizophrenia
- PubMed: AMG 133, a potent and selective mGluR5 antagonist, is therapeutically effective in rat models of anxiety
See Also[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD
